title: Case report of transverse myelitis in a patient receiving etanercept for rheumatoid arthritis.
abstract: Etanercept is a monoclonal antibody targeted against Tumour Necrosis Factor-alpha (TNF-a) which is an effective treatment for rheumatoid arthritis and is in cases where conventional disease modifying agents such as methotrexate have failed. Neurological complications of treatment have been documented. We describe a case of transverse myelitis occurring in a 48 year-old lady with RA since 1994 who had been receiving etanercept for four years.
authors.affiliation: Rheumatology Department, St. Peters Hospital, Guilford Road, Chertsey, Surrey KT16 0PZ, UK.
authors.forename: Helen
authors.initials: H
authors.lastname: Defty
authors.forename: Edward
authors.initials: E
authors.lastname: Sames
authors.forename: Teresa
authors.initials: T
authors.lastname: Doherty
authors.forename: Rodney
authors.initials: R
authors.lastname: Hughes